Unlocking the potential of miR-19b in the regulation of temozolomide response in glioblastoma patients via targeting PPP2R5E, a subunit of the protein phosphatase 2A complex

Despite the standard of care, glioblastoma IDH wildtype (GBM) inevitably recurs, underscoring the need to develop new treatment strategies. To address the role of microRNAs in temozolomide (TMZ) response, we performed functional microRNA screens and consistently identified miR-19b. Our study reveals a novel axis between miR-19b and PPP2R5E subunit of serine/threonine protein phosphatase PP2A and establishes a so far unappreciated contribution of miR-19b in TMZ resistance of GBM. Specifically, our results demonstrate that attenuation of miR-19b in GBM cell lines and glioblastoma stem cells (GSCs) induces DNA damage, which further enhances the cytotoxic effects of TMZ treatment. We confirmed TMZ resistance induced by knocking down PPP2R5E in orthotopic mouse xenografts of GSCs. Furthermore, our results indicate that treating cells with the PP2A-activating drug FTY720 or knocking down endogenous PP2A-inhibiting proteins potentiates the cytotoxic effects of TMZ. MiR-19b attenuation or PPP2R5E activation could potentially be exploited in adjuvant therapy of GBM patients.

[1]  S. Cuzzocrea,et al.  The Pivotal Role of Protein Phosphatase 2A (PP2A) in Brain Tumors , 2022, International journal of molecular sciences.

[2]  E. Vassella,et al.  Pleiotropy of PP2A Phosphatases in Cancer with a Focus on Glioblastoma IDH Wildtype , 2022, Cancers.

[3]  G. Rätsch,et al.  Integrated longitudinal analysis of adult grade 4 diffuse gliomas with long-term relapse interval revealed upregulation of TGF-β signaling in recurrent tumors , 2022, Neuro-oncology.

[4]  M. Aschner,et al.  Protein phosphatase 2A regulates cytotoxicity and drug resistance by dephosphorylating AHR and MDR1 , 2022, The Journal of biological chemistry.

[5]  E. Rojas,et al.  Interactions between miRNAs and Double-Strand Breaks DNA Repair Genes, Pursuing a Fine-Tuning of Repair , 2022, International journal of molecular sciences.

[6]  Qianming Du,et al.  Acquired temozolomide resistance in MGMTlow gliomas is associated with regulation of homologous recombination repair by ROCK2 , 2022, Cell Death & Disease.

[7]  G. Reifenberger,et al.  The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. , 2021, Neuro-oncology.

[8]  A. Unterberg,et al.  Prognostic Value of microRNA-221/2 and 17-92 Families in Primary Glioblastoma Patients Treated with Postoperative Radiotherapy , 2021, International journal of molecular sciences.

[9]  Y. Tu,et al.  TGF-β Signaling Promotes Glioma Progression Through Stabilizing Sox9 , 2021, Frontiers in Immunology.

[10]  Y. Hirose,et al.  Human Glioma Cells Acquire Temozolomide Resistance After Repeated Drug Exposure Via DNA Mismatch Repair Dysfunction , 2020, AntiCancer Research.

[11]  Jeffrey H. Chuang,et al.  LONGITUDINAL MOLECULAR TRAJECTORIES OF DIFFUSE GLIOMA IN ADULTS , 2019, Nature.

[12]  Krister Wennerberg,et al.  PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells , 2018, Science Translational Medicine.

[13]  K. Monastyrskaya,et al.  miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer , 2018, Molecular Cancer.

[14]  G. Fuller,et al.  Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma. , 2018, Journal of neurosurgery.

[15]  Yanto Ridwan,et al.  Click beetle luciferase mutant and near infrared naphthyl-luciferins for improved bioluminescence imaging , 2018, Nature Communications.

[16]  Kyung-Sub Moon,et al.  Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand , 2017, Cancer Cell International.

[17]  S. Burma,et al.  Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma , 2016, Molecular Cancer Research.

[18]  Kuen-Feng Chen,et al.  Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy , 2015, BMC Cancer.

[19]  A. Melcarne,et al.  The DNA damage/repair cascade in glioblastoma cell lines after chemotherapeutic agent treatment , 2015, International journal of oncology.

[20]  Q. Lan,et al.  Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma. , 2015, Neuro-oncology.

[21]  L. Mariani,et al.  miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas , 2014, Cell Death and Disease.

[22]  Giuseppe Schettino,et al.  Use of the γ-H2AX Assay to Investigate DNA Repair Dynamics Following Multiple Radiation Exposures , 2013, PloS one.

[23]  C. Kang,et al.  miR-19a and miR-19b Overexpression in Gliomas , 2013, Pathology & Oncology Research.

[24]  J. Sarkaria,et al.  Inhibition of Histone Deacetylation Potentiates the Evolution of Acquired Temozolomide Resistance Linked to MGMT Upregulation in Glioblastoma Xenografts , 2012, Clinical Cancer Research.

[25]  C. Morrison,et al.  PP2A-B56α Controls Oncogene-Induced Senescence in Normal and Tumor Human Melanocytic Cells , 2011, Oncogene.

[26]  Hyunsuk Shim,et al.  Regulation of miR-19 to Breast Cancer Chemoresistance Through Targeting PTEN , 2011, Pharmaceutical Research.

[27]  A. Sonabend,et al.  Inhibition of Sonic Hedgehog and Notch Pathways Enhances Sensitivity of CD133+ Glioma Stem Cells to Temozolomide Therapy , 2011, Molecular medicine.

[28]  A. Goel,et al.  Supratentorial glioblastoma multiforme with spinal metastases , 2010, Journal of craniovertebral junction & spine.

[29]  H. Piwnica-Worms,et al.  Phosphorylation of Chk1 by ATR Is Antagonized by a Chk1-Regulated Protein Phosphatase 2A Circuit , 2006, Molecular and Cellular Biology.

[30]  R. Mirimanoff,et al.  MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.

[31]  J. Hörandel,et al.  COSMIC RAYS FROM THE KNEE TO THE SECOND , 2007 .

[32]  J. Sneep,et al.  With a summary , 1945 .